Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pure natural drug for treating viral hepatitis

A viral hepatitis, pure natural technology, applied in the direction of antiviral agents, drug combinations, pharmaceutical formulations, etc., can solve problems such as the inability to eradicate hepatitis virus

Inactive Publication Date: 2009-09-09
ZHANJIANG XIANBO TECH
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Generally, comprehensive therapy can only relieve severe symptoms of hepatitis and relieve pain, but cannot eradicate hepatitis virus.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] 1. A pure natural medicine for treating viral hepatitis, which is prepared by weighing medicinal materials according to the weight of the formula composition;

[0015] 2. Strictly follow the aforementioned production process to extract the active ingredients of the drug;

[0016] 3. After mixing and pulverizing the various dry powders obtained, batching, stirring, and passing the test, pack them into capsules to obtain the finished product;

[0017] 4. Oral capsules 0.3 g / capsule, 3 capsules / time for adults, 3 times / day. Reduce dosage for children; take with warm water.

[0018] 5. Precautions: It is forbidden for women during menstrual period; it is forbidden for patients with internal bleeding.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pure natural drug for treating viral hepatitis. The formula weight percentages are as follows: 10% of American ginseng, 10% of astragalus root, 10% of fruit of Chinese magnoliavine, 10% of angelica, 10% of centipede, 10% of scorpion, 10% of earthworm, 6.4% of black-tail snake, 5% of sea snake, 5% of marine algae, 3.4% of climbing fern herb, 3.4% of barbed skullcap, 3.4% of cordate houttuynia and Chinese goldthread. The pure natural drug has main functions of enhancing immunity, detoxicating and diminishing inflammation, promoting blood circulation and removing blood stasis, and opening the nasal orifices and alleviating pain, and has marked effect in treating viral hepatitis.

Description

technical field [0001] The invention relates to human viral hepatitis diseases, which are classified into six types including A, B, C, D, E and G. Specifically, it relates to a natural medicine for treating the above six kinds of viral hepatitis, which is composed of effective active ingredients extracted from various animal and plant medicinal materials. Background technique [0002] Viral hepatitis is the infectious disease with the highest infection rate and incidence rate in my country. According to statistics, there are 120 million hepatitis B virus carriers alone, of which 1 / 10 are symptomatic, about 1 / 4 of patients are chronic, 3% of patients turn into liver cirrhosis, and more than 90% of primary liver cancer is caused by viral hepatitis. There is no ideal specific drug for viral hepatitis at present. General use of comprehensive therapy can only relieve the severe symptoms of hepatitis and relieve pain, but cannot eradicate the hepatitis virus. Therefore, there ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/78A61P1/16A61P31/14A61P31/20A61K35/58A61K35/64A61K35/583A61K35/62A61K35/646A61K35/648
Inventor 莫以贤
Owner ZHANJIANG XIANBO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products